Pharmafile Logo

Patients and data tracking

The end of pharma

Some parts of our industry may go the way of the kitchen display cabinet and the word processor

- PMLiVE

ZPB Associates acquires PR specialist Journalista

Agencies have previously worked together on a number of campaigns

Bristol Myers Squibb logo

BMS scores FDA priority review for Opdivo/Yervoy combo in liver cancer

Possible new treatment for difficult to treat cancer type

- PMLiVE

Merck claims first-ever okay for Ebola vaccine, in Europe

Comes shortly after J&J filed its Ebola candidate with EMA

- PMLiVE

UK biotech Evgen craters on failed stroke trial

Shares in the biotech more than halved following the news

- PMLiVE

Otsuka presses on with Alzheimer’s agitation drug

Surprise announcement comes on the heels of phase 3 trial fail

- PMLiVE

Pharmaceutical innovation in the APAC region

A first-of-its-kind study paints a vivid picture of the APAC region’s future

Patient journey mapping: exploring the clinical and the emotional journey

By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...

OPEN Health

- PMLiVE

Sandoz expands into Japan with €400m Aspen deal

Will gain presence in third largest generics market in the world

Roche Basel Switzerland

Roche’s Spinraza, Zolgensma rival risdiplam hits the mark in SMA

Will file for approval in US and other world markets before end of the year

- PMLiVE

Precision medicine at Blue Latitude Health

At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...

Blue Latitude Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links